Search alternatives:
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
6661
-
6662
-
6663
-
6664
PCAIs inhibit NCI-H23 cell line viability.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
6665
PCAIs disrupt actin filaments in NCI-H23 cells.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
6666
PCAIs suppress 3D NCI-H23 cell invasion.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
6667
PCAIs suppress NCI-H23 cancer cell migration.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
6668
PCAIs induce apoptosis in NCI-H23 cells.
Published 2024“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
-
6669
-
6670
-
6671
-
6672
DNMT1 reduces cisplatin sensitivity partially through downregulating FOXO3a in ovarian cancer cells
Published 2025“…Knocking down of DNMT1 could decrease the IC<sub>50</sub> of cisplatin. Treatment with cisplatin may reduce FOXO3a expression in OC cells. …”
-
6673
-
6674
-
6675
Suppression by extracellular QRNA from TNP Ts Sup free of exosomes, or miR-150 alone, associating with B-cell derived Ag-specific exosomes from the assayed CS-effector cell mixture...
Published 2015“…</b></u> Similarly, two day immune B-1 B cell-derived exosomes, supplemented with decreasing doses of miR-150 alone, mediated suppression of TNP-CS-effector cell adoptive transfer (Groups E-G), down to a dose of 750pg per eventual recipient, which is 50 femtomoles per eventual recipient (Group G). …”
-
6676
Drebrin regulates RMS neuroblast migration <i>in vitro</i>.
Published 2015“…The GFP channel is shown as a grayscale image. (B) Drebrin-depleted neuroblasts (black column) show a ~20% decrease in migration distance compared to control shRNA-nucleofected cells (white column). …”
-
6677
-
6678
-
6679
-
6680
Rho inactivation negatively affects biofilm formation in <i>B</i>. <i>subtilis</i>.
Published 2017“…(B and C) Rho inactivation decreases expression of biofilm-specific genes. Promoters of the operons <i>epsA-O</i> (B) and <i>tapA-sipW-tasA</i> (C) encoding exopolysaccharides and amyloid-like protein fibers, respectively, were fused to the butterfly luciferase gene <i>luc</i> and tested for transcription activity in <i>B</i>. …”